Reaction Details |
| Report a problem with these data |
Target | Promotilin |
---|
Ligand | BDBM85614 |
---|
Substrate/Competitor | n/a |
---|
Ki | 3.6±n/a nM |
---|
Comments | PDSP_6650 |
---|
Citation | Tsukamoto, K; Kuboyama, N; Yamano, M; Nakazawa, T; Suzuki, T In vitro pharmacological profile of SK-896, a new human motilin analogue. Pharmacology60:128-35 (2000) [PubMed] Article |
---|
More Info.: | Get all data from this article |
---|
|
Promotilin |
---|
Name: | Promotilin |
Synonyms: | MLN | MOTI_HUMAN | Motilin | Promotilin |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 12919.83 |
Organism: | Homo sapiens (Human) |
Description: | Motilin 0 HUMAN::P12872 |
Residue: | 115 |
Sequence: | MVSRKAVAALLVVHVAAMLASQTEAFVPIFTYGELQRMQEKERNKGQKKSLSVWQRSGEE
GPVDPAEPIREEENEMIKLTAPLEIGMRMNSRQLEKYPATLEGLLSEMLPQHAAK
|
|
|
BDBM85614 |
---|
n/a |
---|
Name | BDBM85614 |
Synonyms: | [Leu13]motilin | [leu13]pMOT(1-22) |
Type | Small organic molecule |
Emp. Form. | C121H190N34O35 |
Mol. Mass. | 2681.0101 |
SMILES | [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#8])=O |r| |
Structure |
|